NHS England's cancer waiting times data, updated on 15 April 2026, continues to reflect the sustained pressure on oncology services. Against this backdrop, community pharmacists are playing a quietly expanding role in cancer supportive care — managing side effects, counselling on oral anticancer medicines and providing accessible support between hospital appointments.

The shifting landscape

Cancer treatment in the UK has changed significantly over the past decade. Oral anticancer medicines now account for a growing proportion of cancer treatment regimens, meaning patients spend less time in hospital infusion suites and more time managing their treatment at home. This shift places community pharmacists at the front line of day-to-day cancer care.

Additionally, cancer survivorship is rising. Cancer Research UK estimates that there are approximately 3 million cancer survivors in the UK, a figure expected to reach 4 million by 2030. Many of these survivors live with long-term treatment side effects that community pharmacists can help manage.

Managing chemotherapy side effects

Patients undergoing chemotherapy frequently visit their community pharmacy for advice on side effects. Pharmacists should be prepared to advise on:

Nausea and vomiting: Chemotherapy-induced nausea and vomiting (CINV) is managed primarily by the oncology team with prescribed antiemetics, but breakthrough nausea is common. Pharmacists can:

• Reinforce the importance of taking prophylactic antiemetics as prescribed (patients sometimes skip them on "good days")
• Advise on dietary management — small, frequent meals; avoiding strong smells; ginger tea or biscuits for mild nausea
• Ensure the patient has adequate antiemetic supply at home for the expected nadir period
• Refer back to the oncology team if prescribed antiemetics are not controlling symptoms

Oral mucositis: Painful mouth ulceration affects up to 40 per cent of patients receiving certain chemotherapy regimens. Pharmacists can recommend:

• Benzydamine (Difflam) mouthwash or spray for pain relief
• Regular mouthwashes with saline or sodium bicarbonate
• Soft toothbrushes and avoidance of alcohol-based mouthwashes
• Referral to the oncology team if the patient cannot eat or drink due to mouth pain

Diarrhoea and constipation: Chemotherapy regimens cause both, sometimes alternating. Loperamide is appropriate for chemotherapy-induced diarrhoea (patients should have a supply at home), but pharmacists should advise seeking urgent medical help if diarrhoea is severe (more than 6 episodes per day), contains blood, or is accompanied by fever. Opioid-induced constipation from cancer pain management requires proactive laxative prescribing.

Skin and nail changes: Targeted therapies (particularly EGFR inhibitors and kinase inhibitors) cause distinctive skin toxicities. Pharmacists can recommend emollients for dry skin, advise on sun protection (many cancer treatments increase photosensitivity) and provide nail care advice.

Oral anticancer medicines in community pharmacy

Community pharmacists increasingly dispense oral anticancer medicines — capecitabine, enzalutamide, abiraterone, lenalidomide, imatinib, tamoxifen and many others. These medicines require careful handling and specific counselling:

Safe handling: While the risk to pharmacy staff from handling oral anticancer medicines in their final dosage form is low, pharmacists should avoid touching broken or crushed tablets and follow COSHH guidance. Gloves should be worn when handling cytotoxic medicines.

Patient counselling priorities:

Pharmacists should verify the regimen against the patient's treatment plan and be alert to dose modifications that may not yet be reflected in the GP's prescribing system.

Pain management

Cancer pain affects approximately 60 per cent of patients during treatment and up to 90 per cent of those with advanced disease. Community pharmacists contribute through:

• Ensuring timely supply of analgesics, including controlled drugs
• Counselling on the WHO analgesic ladder — paracetamol, weak opioids, strong opioids — and the role of adjuvant medicines (amitriptyline or gabapentin for neuropathic pain)
• Managing opioid side effects proactively: prescribe a laxative with every opioid, advise on drowsiness during dose titration, and ensure patients have breakthrough analgesia available
• Identifying undertreated pain — a patient who is not using their prescribed breakthrough dose may be enduring unnecessary suffering due to opioid fears

Pharmacists should be comfortable discussing strong opioids without stigma. Cancer pain requires adequate treatment, and patients should never feel judged for needing morphine or its equivalents.

Emotional and practical support

Cancer affects every aspect of a patient's life. Pharmacists who see the same patient week after week build a relationship that hospital teams, with their rotating staff and busy clinics, often cannot replicate. Simple actions matter:

• Asking "How are you really doing?" and having time to listen to the answer
• Knowing the patient's name and their treatment schedule
• Offering a private consultation room for sensitive conversations
• Signposting to Macmillan Cancer Support (0808 808 0000), Maggie's Centres, local cancer support groups and financial advice services
• Being aware of carer burden — partners and family members managing cancer care at home need support too

When to refer urgently

Pharmacists must recognise oncological emergencies that require immediate action:

• Neutropenic sepsis: Temperature ≥38°C (or any signs of infection) in a patient within 7–14 days of chemotherapy. Call 999 or instruct the patient to go straight to A&E. Do not treat in pharmacy.
• Spinal cord compression: New back pain with leg weakness, numbness or bladder/bowel changes in a cancer patient. Emergency referral.
• Superior vena cava obstruction: Facial swelling, breathlessness, distended neck veins. Emergency referral.

These presentations can be life-threatening within hours. Pharmacists should err on the side of urgent referral.

Developing cancer pharmacy expertise

For pharmacists wishing to specialise in oncology, career pathways include hospital oncology pharmacy rotations, Macmillan pharmacist roles in primary care, and specialist palliative care pharmacy positions. The PharmSee job board lists vacancies across these settings, and salary data is available in the PharmSee salary guide. The pharmacy finder helps patients locate their nearest community pharmacy for prescription dispensing and supportive care advice.

Sources: NHS England cancer waiting times statistics (updated 15 April 2026); Cancer Research UK survivorship data; NICE NG131 Suspected cancer: recognition and referral (2015, updated 2024); WHO analgesic ladder; UKONS (UK Oncology Nursing Society) oral anticancer therapy guidelines; BNF monographs (accessed April 2026); PharmSee vacancy tracker (April 2026, n=1,715).